Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05832008 · ClinicalTrials.gov registry record · NA

Increasing Adherence to Lung Cancer Screening

A NA study of Lung Cancer and Adherence, Patient, sponsored by Abramson Cancer Center at Penn Medicine.

Active
Registry status
NA
Development phase
825
Enrollment target
1
Study location

NCT05832008 is a NA study of Lung Cancer and Adherence, Patient that is active but no longer recruiting, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 825 participants, below the 934-participant average among 409 other Lung Cancer trials with a reported enrollment target (12% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05832008, a NA study of Lung Cancer and Adherence, Patient, is active but no longer recruiting, sponsored by Abramson Cancer Center at Penn Medicine.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
825 participants
Enrollment target
1
Study location

Study Summary

Investigators are conducting a pragmatic randomized trial testing the effectiveness of patient and clinician nudge strategies on adherence to lung cancer screening (LCS) \& diagnostic follow-up across eligible primary care clinicians \& patients. Following the trial, a subsample of patients \& clinicians will be invited to one-time semi-structured interview \& survey to identify individual \& system-level factors that may restrict or enhance the impact of strategies.

Interventions

  • BEHAVIORAL Patient Nudge
  • BEHAVIORAL Clinician Nudge

Study Locations (1)

Pennsylvania

  • University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 825 participants
Start Date 2023-10-18
Est. Completion 2026-06-01
Phase NA

What the Registry Record Tells You About NCT05832008

The ClinicalTrials.gov registry entry for NCT05832008 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 825 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 934-participant average among 409 other Lung Cancer trials with a reported enrollment target (12% lower). The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 402 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Lung Cancer appearing as the primary indexed condition, and to 2 interventions - of which Patient Nudge is the first listed.

NCT05832008 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT05832008 about?

NCT05832008 is a clinical study titled "Increasing Adherence to Lung Cancer Screening". Investigators are conducting a pragmatic randomized trial testing the effectiveness of patient and clinician nudge strategies on adherence to lung cancer screening (LCS) \& diagnostic follow-up across eligible primary care clinicians \& patients. Following the trial, a subsample of patients \& clini...

What is the current status of trial NCT05832008?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 825 participants. The study started on 2023-10-18. Estimated completion is 2026-06-01.

What conditions does trial NCT05832008 study?

This clinical trial studies the following conditions: Lung Cancer, Adherence, Patient.

What interventions are being tested in trial NCT05832008?

The interventions under investigation include: Patient Nudge (BEHAVIORAL), Clinician Nudge (BEHAVIORAL).

Who is sponsoring clinical trial NCT05832008?

This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05832008 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Lung Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.